Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00202033

Enrollment

150

Registered

2005-09-20

Start date

2004-09-30

Completion date

2009-05-31

Last updated

2015-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

referred to, comprehensive, diabetes, education, program

Brief summary

To determine if the frequency of blood glucose testing in patients with type 2 diabetes who are being treated with diet and exercise alone or diet and exercise plus oral agents will impact the HbA1c level.

Detailed description

To determine the impact of SMBG frequency on blood glucose control in patients receiving systematic diabetes management education through Type 2 Diabetes BASICS at International Diabetes Center.

Interventions

BEHAVIORALfrequency of self monitoring blood glucose

Evaluate the impact of self monitoring blood glucose frequency on glycemic control in patients with type 2 diabetes.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 79 Years

Healthy volunteers

Inclusion criteria

* Type 2 diabetes * Treatment with diet and exercise alone or with the addition of 1 or 2 oral agents * Enrolled in Type 2 BASICS program * A1c between 7.0 and 11%, inclusive * Able to understand spoken English

Exclusion criteria

* Insulin therapy * Unable/unwilling to perform SMBG * Participating in another research study * Currently performing SMBG \>3 times/week

Design outcomes

Primary

Measure	Time frame
HbA1c	2 years

Secondary

Measure	Time frame
blood glucose testing frequency	2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026